R. Phillip Dellinger
45 works · 10,200 citations · h-index 12
Top works
- Surviving Sepsis Campaign
- Steroid therapy of septic shock: The decision is in the eye of the beholder
- Critical care medicine training and certification for emergency physicians*
- Critical care medicine as a distinct product line with substantial financial profitability: The role of business planning
- The authors reply
- Causes of Emergency Department Overcrowding and Blockage of Access to Critical Services in Beijing: A 2-Year Study
- Multi-Center Study of Early Lactate Clearance as a Determinant of Survival in Patients with Presumed Sepsis
- Recent developments in the treatment of sepsis
- PHARMACOLOGIC ISSUES IN THE MANAGEMENT OF SEPTIC SHOCK
- Airway management and nosocomial infection
- Talactoferrin in Severe Sepsis
- Targeting the lipopolysaccharides: still a matter of debate?
- Tumor necrosis factor in septic shock and multiple system trauma
- Placebo and Inhaled Nitric Oxide Mortality the Same in ARDS Clinical Trial
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
- Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial
- CARING FOR CRITICALLY ILL PATIENTS OUTSIDE THE MEDICAL-SURGICAL INTENSIVE CARE UNIT:DOES LOCATION HAVE AN IMPACT ON PATIENT OUTCOMES?
- Separating practice guidelines from pharmaceutical marketing
- Recombinant activated protein C: Decisions for administration
- Outcome assessment - the pros and cons of TISS as the primary objective